Safety and efficacy of aerobic training in patients with cancer who have heart failure: An analysis of the HF-ACTION randomized trial

Journal of Clinical Oncology

Volumn 32, Issue 23, 2014, Pages 2496-2502

  Jones, Lee W ^a   Douglas, Pamela S ^b   Khouri, Michel G ^b   Mackey, John R ^c   Wojdyla, Daniel ^b   Kraus, William E ^b   Whellan, David J ^d   O'Connor, Christopher M ^b  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF ALBERTA   (Canada)

^d THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LOOP DIURETIC AGENT;

AEROBIC EXERCISE; AEROBIC TRAINING; AGED; ARTICLE; BICYCLE ERGOMETRY; BIVENTRICULAR ASSIST DEVICE; CANCER PATIENT; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEART ARRHYTHMIA; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; INTENTION TO TREAT ANALYSIS; LUNG GAS EXCHANGE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PATIENT CARE; PATIENT SAFETY; PRIORITY JOURNAL; PROGRAM EFFECTIVENESS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROSPECTIVE STUDY; THERAPY EFFECT; TREATMENT DURATION; WALKING; CLINICAL TRIAL; EXERCISE; KINESIOTHERAPY; MULTICENTER STUDY; NEOPLASMS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL;

AGED; EXERCISE; EXERCISE THERAPY; FEMALE; HEART FAILURE; HUMANS; MALE; NEOPLASMS; QUALITY OF LIFE; RETROSPECTIVE STUDIES;

EID: 84905845244     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2013.53.5724     Document Type: Article

References (30)

1. Mackey JR, Martin M, Pienkowski T, et al: Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial. Lancet Oncol 14:72-80, 2013
2. Darby SC, Ewertz M, Hall P: Ischemic heart disease after breast cancer radiotherapy. N Engl J Med 368:2527, 2013
3. Oeffinger KC, Mertens AC, Sklar CA, et al: Chronic health conditions in adult survivors of childhood cancer. N Engl J Med 355:1572-1582, 2006 (Pubitemid 44547808)
4. Koelwyn GJ, Khouri M, Mackey JR, et al: Running on empty: Cardiovascular reserve capacity and late effects of therapy in cancer survivorship. J Clin Oncol 30:4458-4461, 2012
5. Khouri MG, Douglas PS, Mackey JR, et al: Cancer therapy-induced cardiac toxicity in early breast cancer: Addressing the unresolved issues. Circulation 126:2749-2763, 2012
6. Yancy CW, Jessup M, Bozkurt B, et al: 2013 ACCF/AHA guideline for the management of heart failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 62:e147-e239, 2013
7. Jensen BV, Skovsgaard T, Nielsen SL: Functional monitoring of anthracycline cardiotoxicity: A prospective, blinded, long-term observational study of outcome in 120 patients. Ann Oncol 13:699-709, 2002 (Pubitemid 34567375)
8. Cardinale D, Colombo A, Lamantia G, et al: Anthracycline-induced cardiomyopathy: Clinical relevance and response to pharmacologic therapy. J Am Coll Cardiol 55:213-220, 2010
9. Mann DL, Krone RJ: Cardiac disease in cancer patients: An overview. Prog Cardiovasc Dis 53:80-87, 2010
10. Belardinelli R, Georgiou D, Cianci G, et al: Randomized, controlled trial of long-term moderate exercise training in chronic heart failure: Effects on functional capacity, quality of life, and clinical outcome. Circulation 99:1173-1182, 1999 (Pubitemid 29120089)
11. Giannuzzi P, Temporelli PL, Corrà U, et al: Antiremodeling effect of long-term exercise training in patients with stable chronic heart failure: Results of the Exercise in Left Ventricular Dysfunction and Chronic Heart Failure (ELVD-CHF) Trial. Circulation 108:554-559, 2003 (Pubitemid 36961169)
12. Hambrecht R, Gielen S, Linke A, et al: Effects of exercise training on left ventricular function and peripheral resistance in patients with chronic heart failure: A randomized trial. JAMA 283:3095-3101, 2000 (Pubitemid 30399720)
13. Wisløff U, Støylen A, Loennechen JP, et al: Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: A randomized study. Circulation 115:3086-3094, 2007 (Pubitemid 46956498)
14. Jones LW, Liang Y, Pituskin EN, et al: Effect of exercise training on peak oxygen consumption in patients with cancer: A meta-analysis. Oncologist 16:112-120, 2011
15. Schmitz KH, Courneya KS, Matthews C, et al: American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med Sci Sports Exerc 42:1409-1426, 2010
16. Jones LW, Alfano CM: Exercise-oncology research: Past, present, and future. Acta Oncol 52:195-215, 2013
17. O'Connor CM, Whellan DJ, Lee KL, et al: Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1439-1450, 2009
18. Whellan DJ, O'Connor CM, Lee KL, et al: Heart failure and a controlled trial investigating outcomes of exercise training (HF-ACTION): Design and rationale. Am Heart J 153:201-211, 2007 (Pubitemid 46096868)
19. Bensimhon DR, Leifer ES, Ellis SJ, et al: Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing). Am J Cardiol 102:712-717, 2008
20. Brooks D, Solway S, Gibbons WJ: ATS statement on six-minute walk test. Am J Respir Crit Care Med 167:1287, 2003
21. Flynn KE, Piña IL, Whellan DJ, et al: Effects of exercise training on health status in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA 301:1451-1459, 2009
22. Haykowsky MJ, Brubaker PH, Stewart KP, et al: Effect of endurance training on the determinants of peak exercise oxygen consumption in elderly patients with stable compensated heart failure and preserved ejection fraction. J Am Coll Cardiol 60:120-128, 2012
23. Edelmann F, Gelbrich G, Düngen HD, et al: Exercise training improves exercise capacity and diastolic function in patients with heart failure with preserved ejection fraction: Results of the Ex-DHF (Exercise training in Diastolic Heart Failure) pilot study. J Am Coll Cardiol 58:1780-1791, 2011
24. Force T, Kolaja KL: Cardiotoxicity of kinase inhibitors: The prediction and translation of preclinical models to clinical outcomes. Nat Rev Drug Discov 10:111-126, 2011
25. Zhang S, Liu X, Bawa-Khalfe T, et al: Identification of the molecular basis of doxorubicin-induced cardiotoxicity. Nat Med 18:1639-1642, 2012
26. Pinder MC, Duan Z, Goodwin JS, et al: Congestive heart failure in older women treated with adjuvant anthracycline chemotherapy for breast cancer. J Clin Oncol 25:3808-3815, 2007 (Pubitemid 47477254)
27. Writing Committee Members, Yancy CW, Jessup M, et al: 2013 ACCF/AHA guideline for the management of heart failure: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 128:e240-e327, 2013
28. Keteyian SJ, Leifer ES, Houston-Miller N, et al: Relation between volume of exercise and clinical outcomes in patients with heart failure. J Am Coll Cardiol 60:1899-1905, 2012
29. Bouchard C, Blair SN, Church TS, et al: Adverse metabolic response to regular exercise: Is it a rare or common occurrence? PloS One 7:e37887, 2012
30. Huang C, Zhang X, Ramil JM, et al: Juvenile exposure to anthracyclines impairs cardiac progenitor cell function and vascularization resulting in greater susceptibility to stress-induced myocardial injury in adult mice. Circulation 121:675-683, 2010